Search

Your search keyword '"Veronese, Federica"' showing total 151 results
Start Over Author "Veronese, Federica"
151 results on '"Veronese, Federica"'

1. Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients

Author

Ferrucci, Silvia, primary, Tavecchio, Simona, additional, Maronese, Carlo Alberto, additional, Balato, Anna, additional, Di Brizzi, Eugenia, additional, Ortoncelli, Michela, additional, Ribero, Simone, additional, Girolomoni, Giampiero, additional, Maurelli, Martina, additional, Belloni Fortina, Anna, additional, Caroppo, Francesca, additional, Naldi, Luigi, additional, Pezzolo, Elena, additional, Nettis, Eustachio, additional, Pugliese, Francesco, additional, Stingeni, Luca, additional, Hansel, Katharina, additional, Rubegni, Giovanni, additional, Calabrese, Laura, additional, Russo, Filomena, additional, Gola, Massimo, additional, Magnaterra, Elisabetta, additional, Rongioletti, Franco, additional, Mercuri, Santo Raffaele, additional, Paolino, Giovanni, additional, Savoia, Paola, additional, Veronese, Federica, additional, Foti, Caterina, additional, Ambrogio, Francesca, additional, Scalvenzi, Massimiliano, additional, Napolitano, Maddalena, additional, Patruno, Cataldo, additional, Dastoli, Stefano, additional, Corazza, Monica, additional, Borghi, Alessandro, additional, Calzavara-Pinton, Pier Giacomo, additional, Rossi, Mariateresa, additional, Offidani, Annamaria, additional, Radi, Giulia, additional, Bonzano, Laura, additional, Ferreli, Caterina, additional, Piras, Viviana, additional, Satta, Rosanna, additional, Sucato, Federica, additional, Malagoli, Piergiorgio, additional, Gaiani, Francesca, additional, Micali, Giuseppe, additional, Musumeci, Maria Letizia, additional, Fargnoli, Maria Concetta, additional, Esposito, Maria, additional, Grieco, Teresa, additional, Chello, Camilla, additional, Casazza, Giovanni, additional, and Marzano, Angelo, additional

Published
2024
Full Text
View/download PDF

3. Trichophyton erinacei‐Infektion beim Menschen: Fallbericht und Literaturübersicht.

Author

Cammarata, Edoardo, Cristo, Nunzia Di, Airoldi, Chiara, Veronese, Federica, Esposto, Elia, Giacomazzi, Claudio, Coppo, Paola, Zavattaro, Elisa, and Savoia, Paola

Abstract

Copyright of Journal der Deutschen Dermatologischen Gesellschaft is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2024
Full Text
View/download PDF

4. Trichophyton erinacei infection in humans: a case report and a literature review.

Author

Cammarata, Edoardo, Cristo, Nunzia Di, Airoldi, Chiara, Veronese, Federica, Esposto, Elia, Giacomazzi, Claudio, Coppo, Paola, Zavattaro, Elisa, and Savoia, Paola

Abstract

Summary: Background: Trichophyton (T.) erinacei is a rare but emerging zoonotic dermatophyte that is rarely isolated as a human pathogen, with only a few cases extensively described in the literature. Patients and Methods: We conducted a systematic search to identify eligible articles reporting demographics, clinical characteristics, and the therapeutic approach regarding T. erinacei infection in humans. Results: 168 patients affected by T. erinacei were reported in the international literature between inception and November 2023. Only 56 cases (32.1%) were fully described. The median age at diagnosis was 26 years, the female/male ratio was around 2:1. The main source of the disease was the hedgehog. The infection presented with a combination of erythema, scaly plaques, pustules, papules, vesicles, oedema, and erosion; the most common locations were the hands and the head. The most frequently conducted examination was fungal culture, but gene sequencing and mass spectrometry improved both speed and precision in the most recent diagnostic course. Topical clotrimazole and systemic terbinafine were the most chosen treatment. Conclusions: Trichophyton erinacei should be considered in patients with erythematous scaly patches and recent contact with hedgehogs. Terbinafine should be considered as a first‐line effective treatment, griseofulvin and azoles could be considered valid alternatives. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Vitis vinifera L. Leaf Extract, a Microbiota Green Ally against Infectious and Inflammatory Skin and Scalp Diseases: An In-Depth Update.

Author

Armari, Marta, Zavattaro, Elisa, Trejo, Cesar Francisco, Galeazzi, Alice, Grossetti, Alessia, Veronese, Federica, Savoia, Paola, and Azzimonti, Barbara

Subjects
VITIS vinifera, LITERATURE reviews, SKIN diseases, PLANT metabolites, METABOLITES
Abstract

The skin microbiota, with its millions of bacteria, fungi, and viruses, plays a key role in balancing the health of the skin and scalp. Its continuous exposure to potentially harmful stressors can lead to abnormalities such as local dysbiosis, altered barrier function, pathobiont overabundance, and infections often sustained by multidrug-resistant bacteria. These factors contribute to skin impairment, deregulation of immune response, and chronic inflammation, with local and systemic consequences. In this scenario, according to the needs of the bio-circular-green economy model, novel harmless strategies, both for regulating the diverse epidermal infectious and inflammatory processes and for preserving or restoring the host skin eubiosis and barrier selectivity, are requested. Vitis vinifera L. leaves and their derived extracts are rich in plant secondary metabolites, such as polyphenols, with antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory properties that can be further exploited through microbe-driven fermentation processes. On this premise, this literature review aims to provide an informative summary of the most updated evidence on their interactions with skin commensals and pathogens and on their ability to manage inflammatory conditions and restore microbial biodiversity. The emerging research showcases the potential novel beneficial ingredients for addressing various skincare concerns and advancing the cosmeceutics field as well. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

Author

Patruno, Cataldo, primary, Fabbrocini, Gabriella, additional, Lauletta, Giuseppe, additional, Boccaletti, Valeria, additional, Colonna, Cristiana, additional, Cavalli, Riccardo, additional, Neri, Iria, additional, Ortoncelli, Michela, additional, Schena, Donatella, additional, Stingeni, Luca, additional, Hansel, Katharina, additional, Piccolo, Vincenzo, additional, Di Brizzi, Veronica, additional, Potenza, Concetta, additional, Tolino, Ersilia, additional, Bianchi, Luca, additional, Manti, Sara, additional, De Pasquale, Rocco, additional, Di Lernia, Vito, additional, Caminiti, Lucia, additional, Galli, Elena, additional, Coppo, Paola, additional, Chiricozzi, Andrea, additional, De Simone, Clara, additional, Guerriero, Cristina, additional, Amoruso, Fabrizio Giuseppe, additional, Provenzano, Eugenio, additional, Leonardi, Salvatore, additional, Licari, Amelia, additional, Marseglia, Gian Luigi, additional, Palermo, Antonino, additional, Di Pillo, Sabrina, additional, Russo, Daniele, additional, Moschese, Viviana, additional, Patella, Vincenzo, additional, Peduto, Tiziana, additional, Ferreli, Caterina, additional, Zangari, Paola, additional, Veronese, Federica, additional, Berti, Samantha Federica, additional, Gruber, Michaela, additional, Pezzolo, Elena, additional, Termine, Stefania, additional, Satta, Rosanna, additional, Dragoni, Federica, additional, Esposito, Maria, additional, Fargnoli, Maria Concetta, additional, Chiodini, Paolo, additional, Vallone, Ylenia, additional, di Vico, Francesca, additional, Picone, Vincenzo, additional, and Napolitano, Maddalena, additional

Published
2023
Full Text
View/download PDF

21. Teledermoscopy in the Diagnosis of Melanocytic and Non-Melanocytic Skin Lesions: NurugoTM Derma Smartphone Microscope as a Possible New Tool in Daily Clinical Practice

Author

Veronese, Federica, primary, Tarantino, Vanessa, additional, Zavattaro, Elisa, additional, Biacchi, Francesca, additional, Airoldi, Chiara, additional, Salvi, Massimo, additional, Seoni, Silvia, additional, Branciforti, Francesco, additional, Meiburger, Kristen M., additional, and Savoia, Paola, additional

Published
2022
Full Text
View/download PDF

22. Facial dermatoses and use of protective mask during Covid-19 pandemic: A clinical and psychological evaluation in patients affected by moderate-severe atopic dermatitis under treatment with dupilumab

Author

Mazzoletti Vanessa, Esposto Elia, Veronese Federica, Cammarata Edoardo, Airoldi Chiara, Graziola Francesca, and Savoia Paola

Subjects
Treatment Outcome, SARS-CoV-2, Eczema, COVID-19, Humans, Dermatology, General Medicine, Antibodies, Monoclonal, Humanized, Pandemics, Severity of Illness Index, Facial Dermatoses, Dermatitis, Atopic
Abstract

During the SARS-COV-2 pandemic, using face masks became mandatory in many countries. Although evidence suggests that masks can exacerbate several inflammatory skin diseases, few studies focus on their real impact on eczema localized to the face in atopic dermatitis (AD) patients. The aim of this study is to evaluate facial eczema prevalence during pandemic and its psychological impact in AD patients pre-assessed for systemic treatment and/or in therapy with dupilumab. This study includes 71 patients affected by moderate-severe AD, treated with dupilumab at SCDU of Dermatology in Novara, Italy. We calculated the number of subjects with facial involvement in pre- and post-pandemic periods and the related localization trend. We evaluated, in the two groups, clinical and psychological indicators recorded at each visit and the score modifications during the observational period. No statistically significant differences were observed in facial eczema prevalence, between pre- and post-pandemic periods (p = 0.7618) and in facial eczema remission among the two groups (p = 0.1903). In post-pandemic period, psychological scores were significantly lower (DLQI and HADS respectively with p 0.0001 and p = 0.0025) and the reduction in EASI score during observational period was significantly greater (p = 0.0001). Our analysis revealed a potential protective effect of masks on face eczema, suggesting that they could enhance dupilumab efficacy. Face masks, covering sensitive areas, can positively contribute to mental distress in patients with facial eczema, and being associated with a lower allergic diseases incidence may sustain dupilumab in reducing AD severity.

Published
2022

23. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry

Author

Chiricozzi, Andrea, Talamonti, Marina, De Simone, Clara, Galluzzo, Marco, Gori, Niccolò, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iris, Lombardo, Maurizio, Feliciani, Claudio, Di Nardo, Lucia, Guarneri, Fabrizio, Peris, Ketty, Caldarola, Giacomo, Silvaggio, Dionisio, Dattola, Annunziata, Napolitano, Maddalena, Ferrucci, Silvia Mariel, Dal Bello, Giacomo, Bianchelli, Tommaso, Rovati, Chiara, Pigliacelli, Flavia, Ortoncelli, Michela, Hansel, Katharina, Calabrese, Giulia, Loi, Camilla, Iannone, Michela, Veronese, Federica, Romita, Paolo, Tronconi, Greta, Caroppo, Francesca, Tilotta, Giovanna, Sernicola, Alvise, Esposito, Maria, Raponi, Francesca, Gualdi, Giulio, Rech, Giulia, Musumeci, Maria Letizia, Nisticò, Steven Paul, Campitiello, Alessio, Bonzano, Laura, Piras, Viviana, Chiricozzi, A., Talamonti, M., De Simone, C., Galluzzo, M., Gori, N., Fabbrocini, G., Marzano, A. V., Girolomoni, G., Offidani, A., Rossi, M. T., Bianchi, L., Cristaudo, A., Fierro, M. T., Stingeni, L., Pellacani, G., Argenziano, G., Patrizi, A., Pigatto, P., Romanelli, M., Savoia, P., Rubegni, P., Foti, C., Milanesi, N., Belloni Fortina, A., Bongiorno, M. R., Grieco, T., Di Nuzzo, S., Fargnoli, M. C., Carugno, A., Motolese, A., Rongioletti, F., Amerio, P., Balestri, R., Potenza, C., Micali, G., Patruno, C., Zalaudek, I., Lombardo, M., Feliciani, C., Di Nardo, L., Guarneri, F., Peris, K., Caldarola, G., Silvaggio, D., Dattola, A., Napolitano, M., Ferrucci, S. M., Dal Bello, G., Bianchelli, T., Rovati, C., Pigliacelli, F., Ortoncelli, M., Hansel, K., Calabrese, G., Loi, C., Iannone, M., Veronese, F., Romita, P., Tronconi, G., Caroppo, F., Tilotta, G., Sernicola, A., Esposito, M., Raponi, F., Gualdi, G., Rech, G., Musumeci, M. L., Nistico, S. P., Campitiello, A., Bonzano, L., Piras, V., Chiricozzi, Andrea, Talamonti, Marina, De Simone, Clara, Galluzzo, Marco, Gori, Niccolò, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iri, Lombardo, Maurizio, Feliciani, Claudio, Di Nardo, Lucia, Guarneri, Fabrizio, Peris, Ketty, Caldarola, Giacomo, Silvaggio, Dionisio, Dattola, Annunziata, Napolitano, Maddalena, Ferrucci, Silvia Mariel, Dal Bello, Giacomo, Bianchelli, Tommaso, Rovati, Chiara, Pigliacelli, Flavia, Ortoncelli, Michela, Hansel, Katharina, Calabrese, Giulia, Loi, Camilla, Iannone, Michela, Veronese, Federica, Romita, Paolo, Tronconi, Greta, Caroppo, Francesca, Tilotta, Giovanna, Sernicola, Alvise, Esposito, Maria, Raponi, Francesca, Gualdi, Giulio, Rech, Giulia, Musumeci, Maria Letizia, Nisticò, Steven Paul, Campitiello, Alessio, Bonzano, Laura, Piras, Viviana, Chiricozzi, A, Talamonti, M, De Simone, C, Galluzzo, M, Gori, N, Fabbrocini, G, Marzano, A, Girolomoni, G, Offidani, A, Rossi, M, Bianchi, L, Cristaudo, A, Fierro, M, Stingeni, L, Pellacani, G, Argenziano, G, Patrizi, A, Pigatto, P, Romanelli, M, Savoia, P, Rubegni, P, Foti, C, Milanesi, N, Belloni Fortina, A, Bongiorno, M, Grieco, T, Di Nuzzo, S, Fargnoli, M, Carugno, A, Motolese, A, Rongioletti, F, Amerio, P, Balestri, R, Potenza, C, Micali, G, Patruno, C, Zalaudek, I, Lombardo, M, Feliciani, C, Di Nardo, L, Guarneri, F, Peris, K, Caldarola, G, Silvaggio, D, Dattola, A, Napolitano, M, Ferrucci, S, Dal Bello, G, Bianchelli, T, Rovati, C, Pigliacelli, F, Ortoncelli, M, Hansel, K, Calabrese, G, Loi, C, Iannone, M, Veronese, F, Romita, P, Tronconi, G, Caroppo, F, Tilotta, G, Sernicola, A, Esposito, M, Raponi, F, Gualdi, G, Rech, G, Musumeci, M, Nistico, S, Campitiello, A, Bonzano, L, and Piras, V

Subjects
Registrie, 0301 basic medicine, Dermatitis, Systemic therapy, 0302 clinical medicine, Pandemic, Immunology and Allergy, Medicine, Registries, atopic dermatitis, COVID, SARS‐ CoV, treatment, SARS-CoV, Atopic dermatitis, Dupilumab, Italy, Original Article, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Human, atopic dermatiti, Adult, medicine.medical_specialty, Teledermatology, SARS‐CoV, atopic dermatitis, treatment, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Communicable Disease Control, Humans, Pandemics, SARS-CoV-2, COVID-19, Dermatitis, Atopic, Atopic, 03 medical and health sciences, Settore MED/35, Disease severity, Internal medicine, business.industry, medicine.disease, 030104 developmental biology, 030228 respiratory system, atopic dermatitis, COVID, SARS-CoV, business
Abstract

Background Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID‐19) pandemic. Methods A national registry, named DA‐COVID‐19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID‐19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. Demographic and clinical data were obtained at different timepoints by teledermatology during COVID‐19 pandemic, when regular visits were not allowed due to sanitary restrictions. Disease severity was assessed by both physician‐ and patient‐reported assessment scores evaluating itch intensity, sleep disturbances, and AD severity. Results A total of 1831 patients were included, with 1580/1831 (86.3%) continuing therapy during pandemic. Most patients were treated with dupilumab (86.1%, 1576/1831) that was interrupted in only 9.9% (156/1576) of cases, while systemic immunosuppressive compounds were more frequently withdrawn. Treatment interruption was due to decision of the patient, general practitioner, or dermatologist in 39.9% (114/286), 5.6% (16/286), and 30.1% (86/286) of cases, respectively. Fear of increased susceptibility to SARS‐CoV‐2 infection (24.8%, 71/286) was one of the main causes of interruption. Sixteen patients (0.9%) resulted positive to SARS‐CoV‐2 infection; 3 of them (0.2%) were hospitalized but no cases of COVID‐related death occurred. Conclusions Most AD patients continued systemic treatments during COVID pandemic and lockdown period, without high impact on disease control, particularly dupilumab‐treated patients., Among 1831 studied AD patients, 86.1% were treated with dupilumab. Patients continuing therapy experienced a marked reduction of disease severity during pandemic. The causes of treatment interruption included: fear of increased susceptibility to SARS‐CoV‐2 infection (24.8%), occurrence of comorbidities (5.9%), age above 60 years (5.2%), SARS‐CoV‐2 infection (2.8%), close contact with SARS‐CoV‐2‐positive subject (2.4%), other reasons, for example, inability to maintain drug supply, non‐medical/unspecified causes (58.7%).

Published
2021

28. Teledermoscopy in the Diagnosis of Melanocytic and Non-Melanocytic Skin Lesions: Nurugo TM Derma Smartphone Microscope as a Possible New Tool in Daily Clinical Practice.

Author

Veronese, Federica, Tarantino, Vanessa, Zavattaro, Elisa, Biacchi, Francesca, Airoldi, Chiara, Salvi, Massimo, Seoni, Silvia, Branciforti, Francesco, Meiburger, Kristen M., and Savoia, Paola

Subjects
*SKIN imaging, *SMARTPHONES, *DIAGNOSTIC errors, *GENERAL practitioners, *DIAGNOSIS, *COMMUNICATIVE disorders
Abstract

Background: Due to the COVID-19 pandemic, teledermoscopy has been increasingly used in the remote diagnosis of skin cancers. In a study conducted in 2020, we demonstrated a potential role of an inexpensive device (NurugoTM Derma) as a first triage to select the skin lesions that require a face-to-face consultation with dermatologists. Herein, we report the results of a novel study that aimed to better investigate the performance of NurugoTM. Objectives: (i) verify whether the NurugoTM can be a communication tool between the general practitioner (GP) and dermatologist in the first assessment of skin lesions, (ii) analyze the degree of diagnostic–therapeutic agreement between dermatologists, (iii) estimate the number of potentially serious diagnostic errors. Methods: One hundred and forty-four images of skin lesions were collected at the Dermatology Outpatient Clinic in Novara using a conventional dermatoscope (instrument F), the NurugoTM (instrument N), and the latter with the interposition of a laboratory slide (instrument V). The images were evaluated in-blind by four dermatologists, and each was asked to make a diagnosis and to specify a possible treatment. Results: Our data show that F gave higher agreement values for all dermatologists, concerning the real clinical diagnosis. Nevertheless, a medium/moderate agreement value was obtained also for N and V instruments and that can be considered encouraging and indicate that all examined tools can potentially be used for the first screening of skin lesions. The total amount of misclassified lesions was limited (especially with the V tool), with up to nine malignant lesions wrongly classified as benign. Conclusions: NurugoTM, with adequate training, can be used to build a specific support network between GP and dermatologist or between dermatologists. Furthermore, its use could be extended to the diagnosis and follow-up of other skin diseases, especially for frail patients in emergencies, such as the current pandemic context. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. North Italy: Welcome to the Tropics!

Author

Veronese, Federica, primary, Graziola, Francesca, additional, Farinelli, Pamela, additional, Zavattaro, Elisa, additional, Tarantino, Vanessa, additional, Esposto, Elia, additional, and Savoia, Paola, additional

Published
2021
Full Text
View/download PDF

30. The Role in Teledermoscopy of an Inexpensive and Easy-to-Use Smartphone Device for the Classification of Three Types of Skin Lesions Using Convolutional Neural Networks

Author

Veronese, Federica, primary, Branciforti, Francesco, additional, Zavattaro, Elisa, additional, Tarantino, Vanessa, additional, Romano, Valentina, additional, Meiburger, Kristen M., additional, Salvi, Massimo, additional, Seoni, Silvia, additional, and Savoia, Paola, additional

Published
2021
Full Text
View/download PDF

31. Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?

Author

Di Cristo, Nunzia, Savoia, Paola, Rossetto, André Luiz, Veronese, Federica, Graziola, Francesca, and Zavattaro, Elisa

Subjects
DERMOSCOPY, CONFOCAL microscopy, SANDY soils
Abstract

Topical treatment with clotrimazole cream for 30 days resulted in partial improvement of the lesion. We probably report the first autochthonous case of I Tinea nigra i (TN) observed in Italy with typical clinical presentation and unusual dermoscopic pattern. After 30 days of clotrimazole cream treatment: Details of partial persistence of the macule. gl TN is a rare, fungal, cosmopolitan infection caused by dematiaceous fungi such as I Hortaea werneckii i , and less frequently by I Stenella araguata i (still under taxonomic discussion). [Extracted from the article]

Published
2023
Full Text
View/download PDF

32. Symmetrical Cutaneous Siderosis of the Upper Limbs.

Author

Zavattaro, Elisa, Veronese, Federica, Farinelli, Pamela, and Savoia, Paola

Subjects
*BUTTOCKS, *IRON, *INTRAMUSCULAR injections, *EXTRAVASATION, *MACULES, *HYPERPIGMENTATION
Abstract

Cutaneous Siderosis is a condition characterized by the hyperpigmentation of the soft tissues resulting from iron leakage occurring during iron replacement therapy. Even if it is a well-known condition, to date only a few reports are available in the literature, mainly describing it as a single lesion developing after intramuscular ferric injection, thus affecting the gluteal region. We report here a case of a 72-year-old patient that developed multiple macules affecting his upper limbs, after repeated intravenous iron extravasations. To our knowledge, this is the first report of Cutaneous Siderosis affecting symmetrically both the upper limbs with numerous elements. [ABSTRACT FROM AUTHOR]

Published
2023

35. Disseminated ulcers with sporotrichoid distribution

Author

Veronese, Federica, primary, Molinari, Rossella, additional, Astolfi, Stefano, additional, Saini, Luigia, additional, Nicali, Roberta, additional, Camaggi, Anna, additional, Andreoni, Stefano, additional, Balbo, Piero Emilio, additional, and Savoia, Paola, additional

Published
2020
Full Text
View/download PDF

36. Disseminierte Ulzera mit sporotrichoider Ausbreitung

Author

Veronese, Federica, primary, Molinari, Rossella, additional, Astolfi, Stefano, additional, Saini, Luigia, additional, Nicali, Roberta, additional, Camaggi, Anna, additional, Andreoni, Stefano, additional, Balbo, Piero Emilio, additional, and Savoia, Paola, additional

Published
2020
Full Text
View/download PDF

37. Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study.

Author

Veronese, Federica, Zavattaro, Elisa, Orioni, Gionathan, Landucci, Gianluca, Tarantino, Vanessa, Airoldi, Chiara, and Savoia, Paola

Subjects
*MEDICAL equipment, *KERATOSIS, *LONGITUDINAL method, *ULTRAVIOLET radiation, *TRANSPLANTATION of organs, tissues, etc.
Abstract

The presence of Actinic Keratoses (AKs) represent the most important warning sign of subclinical ultraviolet radiation. Currently, the regular use of sunscreens is considered essential for the prevention of the development of AKs. We evaluated the effectiveness of a new class I Medical Device (MD) for the prevention and treatment of AKs vs traditional sunscreen alone (SPF 100+). We conducted a randomized controlled prospective study in 90 Caucasian patients: 62 immunocompetent and 28 Organ Transplant Recipients (OTRs). We randomly assigned subjects to the MD group or sunscreen alone in a 1:1 assignment ratio. The patients have been reevaluated after three and six months. In immunocompetent patients treated with MD, at the end of the study the reduction of the mean number of AKs was 54.7 vs. 9.43% with photoprotector. In OTRs, the global reduction was of 36.7% after MD use compared to 14.3% with the sunscreen. The prevalence of NMSCs, in the patients treated with MD, was 11.11 and 17.18 with sunscreen; the incidence was 19.7 in patients treated with MD and 32.1 in those treated with sunscreen. The MD has demonstrated good efficacy in the reduction of visible AKs, encouraging its use also in high-risk category, like OTRs. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

41. Primary trichodysplasia spinulosa polyomavirus infection in a kidney transplant child displaying virus‐infected decoy cells in the urine

Author

Borgogna, Cinzia, primary, Albertini, Silvia, additional, Zavattaro, Elisa, additional, Veronese, Federica, additional, Peruzzi, Licia, additional, Meijden, Els, additional, Feltkamp, Mariet C.W., additional, Tosoni, Antonella, additional, Volpe, Alessandro, additional, Boldorini, Renzo, additional, and Gariglio, Marisa, additional

Published
2019
Full Text
View/download PDF

42. Automatic Extraction of Dermatological Parameters from Nevi Using an Inexpensive Smartphone Microscope: A Proof of Concept

Author

Meiburger, Kristen M., primary, Savoia, Paola, additional, Molinari, Filippo, additional, Veronese, Federica, additional, Tarantino, Vanessa, additional, Salvi, Massimo, additional, Fadda, Matteo, additional, Seoni, Silvia, additional, Zavattaro, Elisa, additional, Santi, Bruno De, additional, and Michielli, Nicola, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results